Acacia Dishman, PhD
- Brain Volkman, PhD, Biochemistry
- Medical Scientist Training Program
Structural biology, NMR, metamorphic proteins, cancer biology
Medical College of Wisconsin, 2017-2021
Advisor: Brian Volkman, PhD
Project: Structure-Function Investigation of Chemokine-GPCR Signaling in Tumor Progression and Metastasis (F30CA236182)
University of Washington, 2020
Advisor: David Baker, PhD
De novo design and characterization of fold switching proteins
University of Michigan, Ann Arbor, 2011-2015
Advisor: Joerg Lahann, PhD
Fabrication of multi-compartmental, biodegradable polymer nano and micro particles for drug delivery applications
Karlsruhe Institute for Technology, Germany, 2014
Advisors: Joerg Lahann, Yvonne Leonie Barner
Fabrication of biphasic, biodegradable polyanhydride micorparticles for Cystic Fibrosis drug delivery applications
Dishman AF, Volkman BF. Design and discovery of metamorphic proteins. Curr Opin Struct Biol. 2022 Jun;74:102380. doi: 10.1016/j.sbi.2022.102380. Epub 2022 May 10. PMID: 35561475.
Dishman AF, He J, Volkman BF, Huppler AR. Metamorphic Protein Folding Encodes Multiple Anti-Candida Mechanisms in XCL1. Pathogens. 2021 Jun 17;10(6):762. doi: 10.3390/pathogens10060762. PMID: 34204234; PMCID: PMC8235156.
Dishman AF, Tyler RC, Fox JC, Kleist AB, et al. Evolution of fold switching in a metamorphic protein. Science. 2021 Jan 1;371(6524):86-90. doi: 10.1126/science.abd8700. PMID: 33384377.
Dishman AF, Peterson FC, Volkman BF. Specific binding-induced modulation of the XCL1 metamorphic equilibrium. Biopolymers. 2020 Sep 28:e23402. doi: 10.1002/bip.23402. Epub ahead of print. PMID: 32986858.
Dishman AF and Lee MW, de Anda J, Lee EY, He J, Huppler AR, Wong GCL, Volkman BF. (2020). Switchable Membrane Remodeling and Antifungal Defense by Metamorphic Chemokine XCL1. ACS Infectious Diseases.
Fox JC, Thomas MA, Dishman AF, Larsen O, Nakayama T, Yoshie O, Rosenkilde MM, Volkman BF. (2019). Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1. Science Signaling.
Dishman AF, Volkman BF. “Unfolding the Mysteries of Protein Metamorphosis.” ACS Chem Biol. 13(6):1438-1446. 2018
S. Rahmani, S. Ashraf, R. Hartmann, A. F. Dishman, M. V. Zyuzin, C. K. J. Yu, W. J. Parak, J. Lahann. "Engineering of Nanoparticle Size via Electrohydrodynamic Jetting." Bioengineering and Translational Medicine, 2016, 1, 82–93.
A. M. Ross, S. Rahmani, D. M. Prieskorn, A. F. Dishman, J. M. Miller, J. Lahann, R. A. Altschuler. "Persistence, distribution, and impact of distinctly segmented microparticles on cochlear health following in vivo infusion." J. Biomedical Materials Research Part A, 2016, 104 (6) 1510-1522.
S. Rahmani, C. H. Villa, A. F. Dishman, M. E. Grabowski, D. C. Pan, H. Durmaz, A. C. Misra, L. Colón-Meléndez, M. J. Solomon,V. R. Muzykantov, J. Lahann. "Long-circulating Janus nanoparticles made by electrohydrodynamic co-jetting for systemic drug delivery applications." J. Drug Targeting, 2015, 23 (7-8), 750-758.
S. Rahmani, T.-H. Park, A. F. Dishman, J. Lahann, “Multimodal Delivery of Irinotecan from Microparticles with Two Distinct Compartments.” J. Control. Release, 2013, 172, 239-245.
S. Rahmani, A. M. Ross, T. H. Park, H. Durmaz, A. F. Dishman, D. Prieskorn, N. Jones, R. Altschuler, J. Lahann. “Dual Release Carriers for Cochlear Delivery.” Adv. Healthcare Mat., 2015, 4, 1-7.
Dishman AF, Tyler RC, Fox JC, et al. Evolution and design of metamorphic proteins as guided by the chemokine XCL1. 2022 Gordon Research Conference on Chemotactic Cytokines. Les Diablerets, Switzerland. June 13, 2022.
Dishman AF, Lee, MW, Fox, JC, Thomas, MA, Wong, GW, Volkman, BF. Structure-activity relationships in the metamorphic, antimicrobial protein XCL1. 34th Annual MD/PhD National Student Conference. Copper Mountain, CO, July, 2020.
Dishman AF, Tyler RC, Fox JC, et al. Evolution and design of fold-switching proteins. Protein Society 35th Anniversary Symposium. Virtual. July 7, 2021.
Dishman AF, Tyler RC, Fox JC, Lee MW, de Anda J, Lee EY, He J, Wong GCL, Volkman BF. Evolution and Functional Advantages of Protein Metamorphosis. Biophysical Society Annual Meeting. San Diego, CA, Feb 2020.
Dishman AF, Tyler RC, Fox JC, et al. Structure-Activity Relationships for the Metamorphic Chemokine XCL1. Chicago Area Nuclear Magnetic Resonance Discussion Group (CANMRDG). Madison, WI, November 2019.
Dishman AF, Lee, MW, Fox, JC, Thomas, MA, Wong, GW, Volkman, BF. Structure-activity relationships in the metamorphic, antimicrobial protein XCL1. Protein Society 33rd Annual Symposium. Seattle, WA, June 2019.
Dishman AF, Peterson FC, Volkman BF. Unfolding the Mysteries of the Metamorphic Chemokine XCL1. Gordon Research Conference and Seminar on Chemotactic Cytokines. Newry, ME, June 2018.
Running, biking, hiking, swimming, camping